Spirochetal diseases such as syphilis, Lyme disease, and leptospirosis are major threats to public health. However, the immunopathogenesis of these diseases has not been fully elucidated. Spirochetes interact with the host through various structural components such as lipopolysaccharides (LPS), surface lipoproteins, and glycolipids. Although spirochetal antigens such as LPS and glycolipids may contribute to the inflammatory response during spirochetal infections, spirochetes such as Treponema pallidum and Borrelia burgdorferi lack LPS. Lipoproteins are most abundant proteins that are expressed in all spirochetes and often determine how spirochetes interact with their environment. Lipoproteins are pro-inflammatory, may regulate responses from both innate and adaptive immunity and enable the spirochetes to adhere to the host or the tick midgut or to evade the immune system. However, most of the spirochetal lipoproteins have unknown function. Herein, the immunomodulatory effects of spirochetal lipoproteins are reviewed and are grouped into two main categories: effects related to immune evasion and effects related to immune activation. Understanding lipoprotein-induced immunomodulation will aid in elucidating innate immunopathogenesis processes and subsequent adaptive mechanisms potentially relevant to spirochetal disease vaccine development and to inflammatory events associated with spirochetal diseases.
INTRODUCTION
Spirochetes are the cause of important human diseases such as syphilis, Lyme disease, and leptospirosis that are major threats to public health (1) . However, the immunopathogenesis of these diseases has not been fully elucidated. Tissue inflammation is characteristic of spirochetal diseases such as dermatitis in syphilis and Lyme disease, interstitial nephritis in leptospirosis, and periodontitis caused by oral treponemes (2, 3) . Spirochetes such as: Treponema pallidum (T. pallidum) and Borrelia burgdorferi (B. burgdorferi), the pathogens for syphilis and Lyme disease, respectively (1), may persist for prolonged periods despite the induced immune responses in the host (4) (5) (6) . Several mechanisms may explain how spirochetes may evade host defenses such as intracellular sequestration of the spirochetes, the antigenic variation of the spirochetes, manipulation of host defenses to delay, and/or suppress the onset of effective immune responses and structural features of the outer membrane in spirochetes that contribute to immune evasion (7) (8) (9) (10) (11) .
Spirochetes have unique membrane structure that interacts with the immune system ( Figure 1) (2, 3, (12) (13) (14) (15) (16) (17) (18) . Although spirochetal antigens such as lipopolysaccharides (LPS), the main proinflammatory component of Gram-negative bacteria (19), and glycolipids may contribute to the inflammatory response during spirochetal infections, spirochetes such as T. pallidum and B. burgdorferi express abundantly membrane lipoproteins and induce strong immune responses (20-24) despite lack of LPS (2, 3, 17, 18) . Thus, lipid-lipid interactions between spirochetes and the lipid rafts in eukaryotic host cells either through glycolipids (3, 25, 26) or lipoproteins (2, 18, 22, 27-31) may occur and these lipid interactions may be an important process that contributes to the immunopathogenesis of spirochetal diseases (3, 25, 26) .
In bacteria, membrane lipoproteins are important virulence factors, pro-inflammatory agonists, enzymes, receptors, modular components of ATP binding cassette (ABC) transporters, and protective immune targets that regulate innate immunity (2, 3) . In contrast to other bacteria that do not express lipoproteins so abundantly (2, 3, 27) , lipoproteins have an important role in the virulence of spirochetes since they are most abundant proteins that are expressed in all spirochetes (2, 3, 18, 22, (27) (28) (29) (30) (31) . The spirochetes express numerous lipoprotein genes [T. pallidum has >20 (24), B. burgdorferi has >100 lipoproteins (23), and approximately 8% of B. burgdorferi genes may encode lipoproteins (21, 23) and Leptospira spp. Have >140 lipoprotein genes (32)]. Examples of abundant lipoproteins in spirochetes include Tp47 of T. pallidum, OspA of B. burgdorferi, LipL32 of Leptospira species, and Vmp proteins of Borrelia species (Table 1) . Finally, spirochetal lipoproteins have more prominent pro-inflammatory effects compared to other bacterial lipoproteins and synthetic lipopeptides (28).
Surface-exposed lipoproteins often determine how spirochetes interact with their environment and immunity ( Figure 1) (2, 3, 18, 22, (27) (28) (29) (30) (31) . Lipoproteins may be present in different cellular compartments (2, 70, 84) and their distribution varies among spirochetes (7, 18, (85) (86) (87) (88) (Figure 1) . The NH2-terminal lipopeptide region is the part of the lipoprotein that confers its immunologic activity since removal of this lipid component removed the immunoregulatory properties of these lipoproteins www.frontiersin.org FIGURE 1 | Structure of spirochetal membrane and lipoproteins. Similarly to gram-positive bacteria, the spirochetal cytoplasmic membrane is associated with the cell wall that consists of peptidoglycan. Similarly to Gram-negative bacteria, spirochetes also have an outer membrane, which is not attached to the peptidoglycan layer. Spirochetes differ phylogenetically from Gram-negative bacteria and interact with the host through various structural components such as lipopolysaccharides (LPS), surface lipoproteins and glycolipids that are present mostly in the outer membrane. LPS has not been identified in Borrelia and Treponema. The periplasmic space contains the flagellum. The distribution of lipoproteins varies among spirochetes and they may be present in different cellular compartments: the outer membrane, the extracellular and the periplasmic spaces. For example the pro-inflammatory lipoproteins of T. pallidum are located below its cell surface and thus do not interact directly with the immune system of the host. It has been suggested that uptake and degradation of T. pallidum releases lipoproteins and allows their interaction with receptors on immune cells leading to immune cell activation. Computational programs can predict spirochetal protein lipidation but do not determine the location of lipoproteins in the cells. Recently, developed fluorescence activated cell sorting (FACS) and surface proteolysis methods can be used to screen for lipoprotein localization. Right upper corner: structure of spirochetal lipoproteins. The finding of a cysteine residue after a signal peptide (+1) is suggestive evidence that a protein is lipidated. The spirochetal lipoproteins have a lipobox that is four amino acids in length and mediates NH2-terminal lipidation on a conserved cysteine residue. Lipoproteins interact with the phospholipids of membranes via three hydrophobic N-terminal acyl moieties (often palmitate; C16) attached to a N-terminal cysteine residue which may contribute to the localization of spirochetal lipoproteins. An analysis of the fatty acids of T. pallidum, B. burgdorferi, L. interrogans phospholipids and lipoproteins found that while fatty acids with different length side chains (C16 and C18) were found in phospholipids, palmitate (C16) predominated in the lipoproteins. The N-terminal tripalmitoyl-S-glyceryl-cysteine (Pam3Cys) lipid moiety is the part of the lipoprotein that confers its immunologic activity. C, cysteine; LPS, lipopolysaccharides.
while synthetic lipopeptides based on this lipid component could activate immune cells (Figure 1 ) (7-11, 18, 28, 89-93) .
In vitro and in vivo studies suggest that spirochetal membrane lipoproteins and lipopeptides are pathogen-associated molecular patterns (PAMPs) that bind to pattern recognition receptors such as toll-like receptors (TLR1, 2). Thus, spirochetal lipoproteins are pro-inflammatory (18, 33, 35-37, 41, 94) by activating endothelial cells (36, (77) (78) (79) (80) 95) and cells of innate immunity such as macrophages and dendritic cells (DCs) (7-11, 38, 42-45, 56, 63, 96, 97) . Spirochetal lipoproteins also enable the spirochetes to evade the immune system (98, 99) and adhere to the host (100-104) or the tick midgut (105, 106) (Table 1) . Finally, lipoproteins may be used as vaccine candidates for prevention of spirochetal infections (2, 3) . The immunoregulatory effects of spirochetal lipoproteins have mostly been determined for major lipoproteins of T. pallidum (e.g., Tp47), B. burgdorferi (e.g., OspA, B), and Leptospira (e.g., LipL32) ( Table 1) . However, most spirochetal lipoproteins have not been well-studied and their interplay with immunity has recently been elucidated (Table S1 in Supplementary Material). Different methods have been used (Table 2) but observations in human models are often different from those obtained in vitro.
Lipoproteins are environmentally regulated and may be expressed selectively during spirochetal infection (37, 50, 112-116) ( Table 1 in Supplementary Material). For example, the outersurface protein (Osp) A has a more important role in the pathogenesis of borrelial infection during the tick phase of B. burgdorferi and its expression is down regulated during the mammalian phase of B. burgdorferi infection (9) . Thus, although OspA does not have a major role in regulation of host immunity in vivo, since it is not expressed during the later stages of borrelial infection, it has been used as a model to study in vitro the immunoregulatory effects of spirochetal lipoproteins (9) . Herein, the immunomodulatory effects of spirochetal lipoproteins are reviewed and are grouped into two main categories: effects related to immune evasion and effects related to immune activation (Figure 2 ). Understanding these mechanisms will aid in elucidating the immunopathogenesis of chronic spirochetal diseases.
THE ROLE OF SPIROCHETAL LIPOPROTEINS IN IMMUNE EVASION
Spirochetes may use outer membrane lipoproteins to invade the host but host immunity may also target these lipoproteins. www.frontiersin.org Table 2 | Methods used to determine in vitro and in vivo immunomodulatory properties of spirochetal lipopeptides/lipoproteins.
Frontiers in Immunology | Microbial Immunology

Method Comments
Mutagenesis However, all pathogenic spirochetes may cause persistent infections in humans by evading the host immune response through multiple mechanisms such as limiting the expression of membrane lipoproteins (85) and their access to antibodies (15, 117) and antigenic variation of surface lipoproteins (Table 1) (2, 98, (118) (119) (120) (121) (122) (123) (124) . Spirochetal lipoproteins may also interact with and inhibit components of innate immunity such as the complement (10, 43, 56, 57, 97, (125) (126) (127) (128) (129) (130) , neutrophils, and serum lipoproteins (131) .
SPIROCHETES USE ANTIGENIC VARIATION OF SURFACE LIPOPROTEINS TO EVADE IMMUNITY
Antigenic variation in borrelias may result from recombination of variable large and small protein genes (122) and the diversity of Vmp lipoproteins allows these pathogens to evade the host immune response (2, 3) . Studies in immunocompromised hosts have suggested that the host immune responses have a major role in producing spirochetal antigenic variants (120) .
SPIROCHETAL LIPOPROTEINS INHIBIT COMPLEMENT ACTIVATION
Spirochetes may evade immune responses by inhibiting complement, a major innate immune system of the host (132, 133 
SPIROCHETAL LIPOPROTEINS INDUCE INFLAMMATORY INFILTRATE INTO TARGET TISSUES AND ADAPTIVE IMMUNE RESPONSES IN VIVO THAT CONTRIBUTE TO CLINICAL MANIFESTATIONS OF SPIROCHETAL DISEASES
Although lipoproteins may activate neutrophils, macrophages, endothelial cells in vitro, they may also induce inflammatory infiltrate into target tissues during spirochetal infection in vivo (37, 50, 61, 94, 115, 116, 164). Lipoproteins may also contribute to the pathogenesis of the Jarisch-Herxheimer reaction, a transient immunological phenomenon that occurs during treatment of spirochetal infections (165, 166) . Injection of synthetic lipopeptides into the skin can also be used to study the immunomodulatory effects of spirochetal lipoproteins in vivo (94). Cutaneous injection of spirochetal lipopeptides and spirochetal skin infections elicit similar cellular infiltrate supporting the hypothesis that spirochetal lipoproteins recruit diverse leukocytes from peripheral blood into target tissues (10 
CONCLUSION
Lipoproteins are widely expressed by many pathogens and have pro-inflammatory effects . Thus, an understanding of how lipoproteins interact with the immune system will aid in the understanding of the pathogenesis of many infections including spirochetal infections. In addition, elucidating the molecular mechanisms of lipoprotein-induced immunomodulation (summarized in Figure 2 ) will lead to a greater understanding of the inflammatory processes, innate and adaptive immune responses associated with spirochetal diseases that may contribute to spirochetal disease vaccine development (163) . 
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